$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

$avdl Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000101247721000011 Filed on August 09, 2021

Income Statement

Concept	2021 Q2	2020 Q2
Revenue	$0.00	$10.09M
YoY Change	-100.0%	-42.51%
Cost Of Revenue	$0.00	$3.285M
YoY Change	-100.0%	-9.3%
Gross Profit	$0.00	$6.806M
YoY Change	-100.0%	-51.15%
Gross Profit Margin		67.45%
Selling, General & Admin	$15.17M	$7.095M
YoY Change	113.87%	4.99%
% of Gross Profit		104.25%
Research & Development	$6.762M	$4.057M
YoY Change	66.67%	-60.58%
% of Gross Profit		59.61%
Depreciation & Amortization	$197.0K	$520.0K
YoY Change	-62.12%	-24.64%
% of Gross Profit		7.64%
Operating Expenses	$21.94M	$11.15M
YoY Change	96.7%	-34.59%
Operating Profit	-$21.94M	$40.27M
YoY Change	-154.47%	-1004.72%
Interest Expense	-$1.930M	-$3.240M
YoY Change	-40.43%	4.18%
% of Operating Profit		-8.05%
Other Income/Expense, Net	$0.00	-$125.0K
YoY Change	-100.0%	150.0%
Pretax Income	-$23.35M	$36.17M
YoY Change	-164.55%	-629.98%
Income Tax	-$3.765M	$5.292M
% Of Pretax Income		14.63%
Net Earnings	-$19.58M	$30.87M
YoY Change	-163.42%	-458.79%
Net Earnings / Revenue		305.96%
Basic Earnings Per Share	-$0.33	$0.57
Diluted Earnings Per Share	-$0.33	$0.49
COMMON SHARES
Basic Shares Outstanding	58.49M shares	54.27M shares
Diluted Shares Outstanding	58.49M shares	69.94M shares

Balance Sheet

Concept	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$204.3M	$238.6M
YoY Change	-14.39%	200.88%
Cash & Equivalents	$67.14M	$102.2M
Short-Term Investments	$137.1M	$136.4M
Other Short-Term Assets	$492.0K	$294.0K
YoY Change	67.35%	258.54%
Inventory		$0.00
Prepaid Expenses	$3.983M	$4.154M
Receivables	$274.0K	$5.692M
Other Receivables	$21.69M	$400.0K
Total Short-Term Assets	$230.7M	$277.0M
YoY Change	-16.72%	185.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$321.0K	$407.0K
YoY Change	-21.13%	-56.42%
Goodwill	$16.84M	$16.84M
YoY Change	0.0%	-8.95%
Intangibles		$0.00
YoY Change		-100.0%
Long-Term Investments		$1.500M
YoY Change		0.0%
Other Assets	$31.50M	$37.62M
YoY Change	-16.26%	8.8%
Total Long-Term Assets	$51.89M	$64.38M
YoY Change	-19.4%	-6.02%
TOTAL ASSETS
Total Short-Term Assets	$230.7M	$277.0M
Total Long-Term Assets	$51.89M	$64.38M
Total Assets	$282.6M	$341.4M
YoY Change	-17.23%	106.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.116M	$4.879M
YoY Change	4.86%	1.69%
Accrued Expenses	$7.524M	$15.82M
YoY Change	-52.44%	0.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$16.28M	$27.02M
YoY Change	-39.74%	-19.54%
LONG-TERM LIABILITIES
Long-Term Debt	$141.8M	$124.9M
YoY Change	13.53%	5.27%
Other Long-Term Liabilities	$4.068M	$5.292M
YoY Change	-23.13%	-54.67%
Total Long-Term Liabilities	$145.8M	$130.2M
YoY Change	12.04%	-0.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.28M	$27.02M
Total Long-Term Liabilities	$145.8M	$130.2M
Total Liabilities	$163.7M	$159.3M
YoY Change	2.78%	-13.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$403.5M	-$361.2M
YoY Change	11.7%	-4.85%
Common Stock	$544.7M	$615.8M
YoY Change	-11.56%	41.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$50.00M
YoY Change		0.0%
Treasury Stock Shares		5.407M shares
Shareholders Equity	$118.9M	$182.1M
YoY Change
Total Liabilities & Shareholders Equity	$282.6M	$341.4M
YoY Change	-17.23%	106.02%

Cashflow Statement

Concept	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$19.58M	$30.87M
YoY Change	-163.42%	-458.79%
Depreciation, Depletion And Amortization	$197.0K	$520.0K
YoY Change	-62.12%	-24.64%
Cash From Operating Activities	-$10.16M	-$7.780M
YoY Change	30.54%	440.28%
INVESTING ACTIVITIES
Capital Expenditures	$4.000K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$18.12M	-$80.89M
YoY Change	-122.4%	-1003.8%
Cash From Investing Activities	$18.13M	-$80.89M
YoY Change	-122.41%	-1003.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.000K	117.3M
YoY Change	-100.0%	-391133.33%
NET CHANGE
Cash From Operating Activities	-10.16M	-7.780M
Cash From Investing Activities	18.13M	-80.89M
Cash From Financing Activities	-1.000K	117.3M
Net Change In Cash	7.968M	28.64M
YoY Change	-72.18%	282.89%
FREE CASH FLOW
Cash From Operating Activities	-$10.16M	-$7.780M
Capital Expenditures	$4.000K	$0.00
Free Cash Flow	-$10.16M	-$7.780M
YoY Change	30.59%	440.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001012477
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	AVADEL PHARMACEUTICALS PLC
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin 2
	dei	Entity Address Country EntityAddressCountry	IE
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L2
	dei	Entity File Number EntityFileNumber	000-28508
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1341933
	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 Earlsfort Terrace
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	D02 T380
	dei	City Area Code CityAreaCode	1
	dei	Local Phone Number LocalPhoneNumber	485-1200
	dei	Security12b Title Security12bTitle	Ordinary Shares, nominal value $0.01 per share**
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58596238	shares
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10091000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22334000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3285000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5742000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6762000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4057000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10614000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9587000	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15174000	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7095000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26186000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15008000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	203000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	406000	USD
CY2021Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2020Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	918000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3396000	USD
CY2021Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	45760000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	45760000	USD
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2020Q2	us-gaap	Restructuring Charges RestructuringCharges	24000	USD
	us-gaap	Restructuring Charges RestructuringCharges	-53000	USD
	us-gaap	Restructuring Charges RestructuringCharges	183000	USD
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	21936000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	-30178000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	36747000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	-11438000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-21936000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	40269000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-36747000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	33772000	USD
CY2021Q2	us-gaap	Investment Income Net InvestmentIncomeNet	432000	USD
CY2020Q2	us-gaap	Investment Income Net InvestmentIncomeNet	-741000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	1042000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	-1119000	USD
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1930000	USD
CY2020Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3237000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3859000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	6427000	USD
CY2021Q2	avdl	Gain Loss On Release Of Certain Liabilities GainLossOnReleaseOfCertainLiabilities	88000	USD
CY2020Q2	avdl	Gain Loss On Release Of Certain Liabilities GainLossOnReleaseOfCertainLiabilities	0	USD
	avdl	Gain Loss On Release Of Certain Liabilities GainLossOnReleaseOfCertainLiabilities	166000	USD
	avdl	Gain Loss On Release Of Certain Liabilities GainLossOnReleaseOfCertainLiabilities	0	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-125000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-435000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-23346000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36166000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39398000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	25791000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3765000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5292000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6372000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4218000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	30874000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	USD
	us-gaap	Net Income Loss NetIncomeLoss	30009000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58488000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54272000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58465000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47665000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58488000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69942000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58465000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63083000	shares
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	30874000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	USD
	us-gaap	Net Income Loss NetIncomeLoss	30009000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	116000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	182000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-602000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-78000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-81000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-133000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-130000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-160000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	927000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-697000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	283000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-44000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1109000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1299000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	288000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19625000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	31983000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34325000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30297000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67142000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71722000	USD
CY2021Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	135701000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	149680000	USD
CY2021Q2	avdl	Research And Development Tax Credit Receivable Current ResearchAndDevelopmentTaxCreditReceivableCurrent	2551000	USD
CY2020Q4	avdl	Research And Development Tax Credit Receivable Current ResearchAndDevelopmentTaxCreditReceivableCurrent	3326000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25308000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38726000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	230702000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	263454000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	321000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	359000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2249000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2604000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	16836000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	16836000	USD
CY2021Q2	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	983000	USD
CY2020Q4	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	3445000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	31500000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24939000	USD
CY2021Q2	us-gaap	Assets Assets	282591000	USD
CY2020Q4	us-gaap	Assets Assets	311637000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	494000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	474000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	5116000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2934000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7524000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6501000	USD
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3146000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5200000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	16280000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15109000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	141774000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	128210000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1589000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1840000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4068000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4212000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	163711000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	149371000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	488000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	488000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	488000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	488000	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	5000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	5000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58488000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58488000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58396000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58396000	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	584000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	583000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	544094000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	566916000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-403453000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-384187000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-22350000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21051000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	118880000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	162266000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	282591000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	311637000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	162266000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-13445000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1255000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	106000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	43000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1728000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	136504000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-44000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2001000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	118880000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-29199000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-865000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-821000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1389000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60733000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	88000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	742000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	32067000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	30874000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1109000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	393000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-94000	USD
CY2020Q2	avdl	Stock Issued During Period Value Public Offering StockIssuedDuringPeriodValuePublicOffering	116974000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	33000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	769000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	182125000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	USD
	us-gaap	Net Income Loss NetIncomeLoss	30009000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	417000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	975000	USD
	avdl	Acquisition Related Contingent Consideration Remeasurement AcquisitionRelatedContingentConsiderationRemeasurement	0	USD
	avdl	Acquisition Related Contingent Consideration Remeasurement AcquisitionRelatedContingentConsiderationRemeasurement	3396000	USD
	avdl	Financing Related Contingent Consideration Remeasurement FinancingRelatedContingentConsiderationRemeasurement	0	USD
	avdl	Financing Related Contingent Consideration Remeasurement FinancingRelatedContingentConsiderationRemeasurement	435000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	625000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3193000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6228000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	161000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3729000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1511000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	45760000	USD
	avdl	Gain Loss On Release Of Certain Liabilities GainLossOnReleaseOfCertainLiabilities	166000	USD
	avdl	Gain Loss On Release Of Certain Liabilities GainLossOnReleaseOfCertainLiabilities	0	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	757000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	477000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2589000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1353000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3106000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1149000	USD
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	-3078000	USD
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	-2036000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	176000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1550000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1199000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6906000	USD
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	0	USD
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	321000	USD
	avdl	Earn Out Payment In Excess Of Acquisition Date Fair Value EarnOutPaymentInExcessOfAcquisitionDateFairValue	0	USD
	avdl	Earn Out Payment In Excess Of Acquisition Date Fair Value EarnOutPaymentInExcessOfAcquisitionDateFairValue	3736000	USD
	us-gaap	Payments For Royalties PaymentsForRoyalties	0	USD
	us-gaap	Payments For Royalties PaymentsForRoyalties	608000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1021000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	3458000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33566000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19417000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	16500000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	14500000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	66213000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15716000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	53372000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	97878000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29315000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67662000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	60639000	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	116974000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	149000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1903000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	149000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	179516000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-478000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-37000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4580000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	92400000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71722000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9774000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67142000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102174000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3234000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3234000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1795000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	0	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	0	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	134688000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1486000	USD
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	473000	USD
CY2021Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	135701000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	147903000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1815000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	38000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	149680000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	41000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	14000	USD
CY2021Q2	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	39000	USD
CY2020Q2	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	6000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	52000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	290000	USD
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	107000	USD
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	878000	USD
CY2020Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	16836000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	16836000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	203000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	406000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2021Q2	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	0	USD
CY2019Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	17327000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4344000	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	3831000	USD
	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	14900000	USD
CY2020Q2	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	1914000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	141774000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	128210000	USD
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1930000	USD
CY2020Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3237000	USD
CY2020Q2	avdl	Coupon Interest Expense CouponInterestExpense	1617000	USD
CY2021Q2	avdl	Coupon Interest Expense CouponInterestExpense	1617000	USD
CY2021Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	313000	USD
CY2020Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1620000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3859000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	6427000	USD
	avdl	Coupon Interest Expense CouponInterestExpense	3234000	USD
	avdl	Coupon Interest Expense CouponInterestExpense	3234000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	625000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3193000	USD
CY2018Q1	avdl	American Depository Shares Conversion Ratio AmericanDepositorySharesConversionRatio	92.6956	Rate
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3765000	USD
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.161
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5292000	USD
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.146
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6372000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.162
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4218000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.164
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	3078000	USD
CY2020Q4	avdl	Short Term Note Receivable ShortTermNoteReceivable	16500000	USD
CY2021Q2	us-gaap	Other Assets Current OtherAssetsCurrent	492000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3143000	USD
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	2036000	USD
CY2021Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	306000	USD
CY2020Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	341000	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3983000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1018000	USD
CY2021Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1418000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1477000	USD
CY2021Q2	avdl	Guarantee Current GuaranteeCurrent	274000	USD
CY2020Q4	avdl	Guarantee Current GuaranteeCurrent	318000	USD
CY2021Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18835000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18615000	USD
CY2021Q2	avdl	Short Term Note Receivable ShortTermNoteReceivable	0	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	457000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25308000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38726000	USD
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24484000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	18256000	USD
CY2021Q2	avdl	Guarantee Noncurrent GuaranteeNoncurrent	910000	USD
CY2020Q4	avdl	Guarantee Noncurrent GuaranteeNoncurrent	1050000	USD
CY2021Q2	avdl	Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent	5749000	USD
CY2020Q4	avdl	Operating Lease Right Of Use Asset Contract Manufacturing Noncurrent OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent	5201000	USD
CY2021Q2	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	357000	USD
CY2020Q4	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	432000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	31500000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24939000	USD
CY2021Q2	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	1504000	USD
CY2020Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	1697000	USD
CY2021Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	177000	USD
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	520000	USD
CY2021Q2	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	821000	USD
CY2020Q4	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	1030000	USD
CY2021Q2	avdl	Accrued Outsource Contract Costs AccruedOutsourceContractCosts	837000	USD
CY2020Q4	avdl	Accrued Outsource Contract Costs AccruedOutsourceContractCosts	473000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4185000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2781000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7524000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6501000	USD
CY2021Q2	avdl	Accrued Interest Current AccruedInterestCurrent	2695000	USD
CY2020Q4	avdl	Accrued Interest Current AccruedInterestCurrent	2695000	USD
CY2021Q2	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	0	USD
CY2020Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	2026000	USD
CY2021Q2	avdl	Other Guarantor Obligations Current Carrying Value OtherGuarantorObligationsCurrentCarryingValue	275000	USD
CY2020Q4	avdl	Other Guarantor Obligations Current Carrying Value OtherGuarantorObligationsCurrentCarryingValue	319000	USD
CY2021Q2	avdl	Other Liabilities Miscellaneous Current OtherLiabilitiesMiscellaneousCurrent	176000	USD
CY2020Q4	avdl	Other Liabilities Miscellaneous Current OtherLiabilitiesMiscellaneousCurrent	160000	USD
CY2021Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3146000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5200000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3143000	USD
CY2021Q2	us-gaap	Guaranty Liabilities GuarantyLiabilities	913000	USD
CY2020Q4	us-gaap	Guaranty Liabilities GuarantyLiabilities	1053000	USD
CY2021Q2	us-gaap	Other Long Term Debt OtherLongTermDebt	12000	USD
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	16000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4068000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4212000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-19581000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	30874000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33026000	USD
	us-gaap	Net Income Loss NetIncomeLoss	30009000	USD
CY2021Q2	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2020Q2	us-gaap	Dilutive Securities DilutiveSecurities	3237000	USD
	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Dilutive Securities DilutiveSecurities	6427000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-19581000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	34111000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-33026000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	36436000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58488000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54272000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58465000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47665000	shares
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15670000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15418000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58488000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69942000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58465000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63083000	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15586	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2472	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15426	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2537	shares
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-78000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-81000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-133000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-130000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10091000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22334000	USD
	avdl	Percentage Of Royalty Payable On Net Sales PercentageOfRoyaltyPayableOnNetSales	0.15
CY2021Q2	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	1188000	USD
CY2021Q2	avdl	Guarantee Asset Current Carrying Value GuaranteeAssetCurrentCarryingValue	1184000	USD

Files In Submission

Name	View Source	Status
0001012477-21-000011-index-headers.html	Edgar Link	pending
0001012477-21-000011-index.html	Edgar Link	pending
0001012477-21-000011.txt	Edgar Link	pending
0001012477-21-000011-xbrl.zip	Edgar Link	pending
avdl-20210630.htm	Edgar Link	pending
avdl-20210630.xsd	Edgar Link	pending
avdl-20210630_cal.xml	Edgar Link	unprocessable
avdl-20210630_def.xml	Edgar Link	unprocessable
avdl-20210630_htm.xml	Edgar Link	completed
avdl-20210630_lab.xml	Edgar Link	unprocessable
avdl-20210630_pre.xml	Edgar Link	unprocessable
exhibit311q22021.htm	Edgar Link	pending
exhibit312q22021.htm	Edgar Link	pending
exhibit321q22021.htm	Edgar Link	pending
exhibit322q22021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

2021 Q2 Form 10-Q Financial Statement

#000101247721000011 Filed on August 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL AVADEL PHARMACEUTICALS PLC Stock $avdl

2021 Q2 Form 10-Q Financial Statement

#000101247721000011 Filed on August 09, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl